ANTI-TUMORAL COMPOSITION

A pharmaceutical composition characterised in that it comprises at least one poxvirus, a naked nucleic acid sequence encoding at least one specific neoantigen of a cancerous cell and an anti-CTLA4 antibody.

Saved in:
Bibliographic Details
Main Author Jean-Marc LIMACHER
Format Patent
LanguageChinese
English
Published 14.06.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A pharmaceutical composition characterised in that it comprises at least one poxvirus, a naked nucleic acid sequence encoding at least one specific neoantigen of a cancerous cell and an anti-CTLA4 antibody.
Bibliography:Application Number: HK20180112608